MIF ELISA KIT, Human

4°C

MIF ELISA KIT, Human

Human

1. Human MIF Standard 600?L 1vial
2. Standard and AntibodyHRP Diluent Buffer 30mL 1bottle
3. MIF Antibody-coated wells 96wells 1plate
4. Peroxidase Conjugate 1mL 1vial
5. Stabilized Chromogen 12mL 1bottle
6. Stop Solution 20mL 1bottle
7. Wash Buffer Concentrate(20X) 30mL 1bottle
8. Accessories 2 adhesive strips

[Supplementary]
Sandwich
[Applicable sample]
serum, body fluid, buffered solution, cell culture medium
[Other]
Macrophage migration inhibitory factor (MIF) is the first T-cell-derived soluble lymphokine identified. It inhibits the random migration of macrophage out of capillary tubes and is profoundly involved in delayed-type hypersensitivity. Through the past few years, previously unrecognized properties of MIF have been discovered. In 1989, Human MIF cDNA was first cloned from activated-T-cells, demonstrating that this protein consists of 114 amino acid residues.The 25 amino acids from N-terminal of the rat MIF (13K protein) show 35% sequence homology with that of the rat glutathion S-transferase (GST) Yb subunit. This finding indicates that MIF is a unique protein linking the immune system with the detoxification system.
Recently, unexpected properties of this protein have been revealed.MIF works as an anterior pituitary-derived hormone, potentiating lethal endotoxaemia, and overrides the glucocorticoid-mediated suppression of inflammatory and immune responses. It was also found to play an essential role in the activation of T-cells after mitogenic or antigenic stimuli. On the other hand, it is reported that MIF mRNAexpression is correlated with differntiation of lens cells, suggesting the involvement of MIF in cellular proliferation and differentiation, and the presence of MIF protein was mostly limited to the basal layer. These results suggest that MIF may haveroles beyond the immune system.
Addition to these properties , MIF is expressed in a wide variety of organs, including the brain, kidney, and liver, and in a variety cells, suggesting its involvement in various pathophysiological phenomena beyondthe immune system. Moreover the primary amino acid sequence identity between MIF molecules from various species is greater than 80%, suggesting MIF may be factor as homeostasis of cells. In this context, MIF should become a major target for the investigation of broad-spectrum pathophysiology and may be applicable for clinical therapeutic use in various disease in the near future, and MIF must be widely remarkable for its importance.